"The Northern Illinois Cancer Treatment Center is located on Illinois Route 2. Cancer may be frightening, but with advanced technology and the right people, it is far from unbeatable. If your doctor recommends radiation therapy as part of your treatment plan, you can be assured that The Northern Illinois Cancer Treatment Center offers the latest cancer treatment radiation technology, delivered in a welcoming, comfortable and friendly environment."

During the past decade, Illinois CancerCare-Dixon conducted 124 clinical trials. In the 10-year time frame, 124 clinical trials started and 9 clinical trials were completed, i.e. on average, 7.3% percent of trials that started reached the finish line to date. In the past 5 years, 79 clinical trials started and 9 clinical trials were completed. i.e. 11.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois CancerCare-Dixon" #1 sponsor was "National Cancer Institute (NCI)" with 55 trials, followed by "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "SWOG Cancer Research Network" with 20 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "Wake Forest University Health Sciences" with 17 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois CancerCare-Dixon" #1 collaborator was "National Cancer Institute (NCI)" with 69 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Brain Science Foundation" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Illinois CancerCare-Dixon" are "Stage IV Lung Cancer AJCC v8" (11 trials), "Stage IVA Lung Cancer AJCC v8" (8 trials), "Stage IVB Lung Cancer AJCC v8" (8 trials), "Invasive Breast Carcinoma" (7 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (6 trials). Many other conditions were trialed in "Illinois CancerCare-Dixon" in a lesser frequency.

Most popular intervention types in "Illinois CancerCare-Dixon" are "Drug" (93 trials), "Other" (69 trials), "Biological" (54 trials), "Procedure" (51 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (37 trials), "Computed Tomography" (34 trials), "Biospecimen Collection" (33 trials), "Questionnaire Administration" (33 trials) and "Magnetic Resonance Imaging" (23 trials). Other intervention names were less common.

The vast majority of trials in "Illinois CancerCare-Dixon" are 112 trials for "All" genders, 9 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Illinois CancerCare-Dixon". undefined are not yet recruiting, 72 are recruiting, 43 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Illinois CancerCare-Dixon, 5 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Illinois CancerCare-Dixon, 1 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".